Mechanistically, VB directly binds and downregulates CCN1, an oncogenic factor highly expressed in OC, inhibiting the AKT/NF-κB pathway, which plays a central role in regulating tumor progression and macrophage polarization. Here, NFKB1 is linked to neoplasm.